Home › Cigna Demands Counseling for Breast Cancer Test in Myriad Threat
 

Keywords :   


Cigna Demands Counseling for Breast Cancer Test in Myriad Threat

2013-08-19 09:48:37| Biotech - Topix.net

Cigna Corp. will become the first U.S. health insurer to require genetic counseling nationwide before it pays for tests for hereditary breast and ovarian cancer, a move that may threaten sales for Myriad Genetics Inc. The policy affects tests for the BRCA1 and BRCA2 genes, the most common cause of hereditary breast cancer, as well as genes for ... (more)

Tags: test cancer demands threat

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Print Quest invests in two more Miraclon Shine LED lamp kits
03.07ETI celebrates grand opening of new headquarters in Spain
03.07Mondi unveils FlexiBag Reinforced
03.07Nilpeter announces new partnership in the Philippines
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 20
03.07Hurricane Beryl Public Advisory Number 20
03.07Summary for Hurricane Beryl (AT2/AL022024)
More »